Email this article 
Hide
Show all
Opinion Paper
When to start ART in adults? The results of HPTN 052 move us closer to a test-and-treat policy
Southern African Journal of HIV Medicine | Vol 12, No 3 | a178 |
DOI: https://doi.org/10.4102/sajhivmed.v12i3.178
| © 2011 Nathan Geffen
| This work is licensed under CC Attribution 4.0
Submitted: 15 December 2011 | Published: 30 September 2011
Submitted: 15 December 2011 | Published: 30 September 2011
About the author(s)
Nathan Geffen, Treatment Action Campaign, South AfricaAbstract
When is the best time to initiate antiretroviral therapy (ART) in adults? This is a vital question in HIV treatment and prevention services. More specifically, is the 350 cells/µl CD4 count threshold recommended by current World Health Organization (WHO) guidelines sufficient, or should we move to a ‘test-and-treat’ approach in which anyone who tests HIV-positive is offered ART, irrespective of their CD4 count? The recently announced results of the HPTN 052 trial take us closer, but not all the way, to a test-and-treat approach.
Keywords
No related keywords in the metadata.
Metrics
Total abstract views: 2593Total article views: 3649
Crossref Citations
1. Provision of Antiretroviral Therapy in South Africa: The Nuts and Bolts
Linda-Gail Bekker, Francois Venter, Karen Cohen, Eric Goemare, Gilles Van Cutsem, Andrew Boulle, Robin Wood
Antiviral Therapy vol: 19 issue: 3_suppl first page: 105 year: 2014
doi: 10.3851/IMP2905